RG6852
/ Genentech, Roche
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
June 12, 2026
A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer
(clinicaltrials.gov)
- P1/2 | N=260 | Recruiting | Sponsor: Genentech, Inc. | Not yet recruiting ➔ Recruiting
Enrollment open • Genito-urinary Cancer • Oncology • Prostate Adenocarcinoma • Prostate Cancer • Solid Tumor
May 06, 2026
A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer
(clinicaltrials.gov)
- P1/2 | N=260 | Not yet recruiting | Sponsor: Genentech, Inc.
New P1/2 trial • Genito-urinary Cancer • Oncology • Prostate Adenocarcinoma • Prostate Cancer • Solid Tumor
1 to 2
Of
2
Go to page
1